Navigation Links
Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08
Date:2/25/2008

Connect IQ for HealthVault Empowers Patients to Orchestrate Health

Information Mobility

PORTLAND, Ore., Feb. 25 /PRNewswire/ -- Kryptiq, the leading provider of next generation healthcare connectivity solutions, today announced the first public demonstration of secure messaging between physician offices and patients using Microsoft(R) HealthVault(TM), at the 2008 HIMSS (Healthcare Information and Management Systems Society) Conference. Connect IQ(TM) for HealthVault now allows consumers to view, save and send clinical information from within their HealthVault account, improving coordination of care. Connect IQ for HealthVault is also tightly integrated with Kryptiq's Connect IQ(TM) Patient Portal, enabling health organizations to leverage HealthVault in strengthening the relationship between physicians and their patients.

When HealthVault was first launched in October 2007, consumers were given the ability to collect and store their health data in a secure online environment. Now patients and physicians can exchange problem and medication lists, lab and radiology reports, care plans and home monitored clinical data -- all essential elements to improving the co-ordination of care, especially for a patient under the care of more than one physician.

"Patients are frustrated with having to demand paper copies of their medical information, and even more frustrated when their physicians don't seem to be communicating with each other," said Peter Neupert, corporate vice president for the Health Solutions Group at Microsoft Corp. "The combination of Microsoft HealthVault and Kryptiq's Connect IQ enables patients to securely access, manage and share their medical information leading to better decisions that impact their health and well-being."

Connect IQ for HealthVault benefits from recent industry momentum towards standards for interoperability. Recent data standards, such as the Consumer Empowerment Interop
'/>"/>

SOURCE Kryptiq Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Kryptiq Customer Receives HIMSS Nicholas E. Davies Award of Excellence
2. Regence Automates Provider Contracting with Kryptiqs Choreo Contract Manager
3. Providence Health & Services - Oregon Region Powers Consumer Portal With Kryptiq Connect IQ
4. CoxHealth Deploys Kryptiq ePrescribing Solution
5. Microsoft Launches Fund to Enable Patient-Centric Health Solutions
6. Microsoft Joins Forces with SAP America for Healthcare IT
7. Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections
8. Microsoft to Showcase Innovative Solutions for Healthcare Providers and Consumers at HIMSS 2008 Annual Conference & Exhibition
9. Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings
10. Microsoft Announces the Amalga Family of Health Enterprise Systems
11. Microsoft Dynamics CRM 4.0 Users now can include Telephony and Call Recording features by adding ConversationPRO(TM) from VoiceGate, a Division of IgeaCare Systems Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...21 U.S. News & Worl...surance (NCQA) ranked BlueChoice(R) HealthPlan of ...Health Plans(TM), published in U.S. News & Wor...ted annual ranking ranks the nation,s best health ...on and NCQA accreditation scores. NCQA and U.S. Ne...
(Date:11/21/2008)... Nov. 21 Today, prescrip...ention in treating 88 percent of patients sufferin... treated for a chronic condition account for 96 pe...cent of all medical costs. A proprietary new phar...lth Solutions, Inc. (NYSE: MHS ) significantly r...
(Date:11/21/2008)... drugs do not cause genetic damage that can lead t... News) -- Two popular medications for treating att...t cause genetic damage linked to an increased risk... study, done by researchers at Duke University Med... counters a previous one that reported biomarkers ...
(Date:11/21/2008)...and deadly diseaseits cause remains a mysteryswept...ing with citizens, soldiers and refugees of the wa...s filled with corpses, social order broke down. Ov...e and Athens lost a third of its population. It lo...ginning of the end of the Golden Age of Greece. ,...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ing a panic disorder may benefit more from treatme...ication instead // of the care usually offered by ...bling and costly anxiety disorders. In the study, ...nic disorder were randomly assigned to receive tre...
...t forgotten the thalidomide tragedy thalidomide in...tment of morning sickness // to pregnant mothers a.... Now, doctors see a new future use for the infamo...maintain their weight. The effects of this drug we...
...dy in Journal of Dental Research, caries in primar...nt teeth.// A primary tooth can have caries for a...alth or history, socio-economic status, years of e...ce to primary teeth, and early loss of primary tee...
...e of Journal of American Medical Association, rese...growing// trend in delaying the vaccination schedu...of the vaccinated diseases affecting the children....of the vaccines that need to be completed during t...
Other Medicine News:
(Date:11/19/2008)...ent from Roche- , , MONTVALE, N.J., Nov. 19...Corp. (Nasdaq: MEMY ) today announced that it ha...al of R3487/MEM 3454, its lead alpha-7 nicotinic r...d with schizophrenia (CIAS). The Company has rand...ng a $5.0 million payment from its partner Roche. ...
(Date:11/18/2008)...Newswire/ -- Arlington Medical Resources (AMR), a,...harmaceutical and diagnostic,imaging industries, ...gen was,sold in the U.S. during the third quarter...nous immune globulin (IVIG) and was launched in th...d from the blood plasma of thousands,of donors an...
(Date:11/18/2008)...oll newly diagnosed, elderly AML patients , ,...r Pharmaceuticals today announced that the first p...inical study of CPX-351 (Cytarabine:Daunorubicin) ...d acute myeloid leukemia (AML). , , The fir... Weill Medical College of Cornell University and...
(Date:11/13/2008)...ch Finds Statins Cut Risk of Heart Attacks, Deaths... Cardiovascular Disease,is the leading cause of de... hundreds of millions of dollars and causing untol...this fatal disease - even among those who,weren,t ...t millions of people could cut their risk of a,hea...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Seniors Can Be Heartened by New Study on Statins 2Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 1Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 2Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 3Autism Society of America Hosts Day on the Hill 13449 1Autism Society of America Hosts Day on the Hill 13449 2Rare Gene Mutation Plays Role in Longevity 13445 1Rare Gene Mutation Plays Role in Longevity 13445 2Rare Gene Mutation Plays Role in Longevity 13445 3Women are treated less frequently than men with statins aspirin and beta blockers 13441 1Women are treated less frequently than men with statins aspirin and beta blockers 13441 2
...INCETON, N.J., June 14, 2007 /PRNewswire-FirstCall...tical company,committed to discovering, developing...fections, announced today that scientific,data pre...uring the,16th International HIV Drug Resistance W...une 12-15, 2007. The poster presentations,are avai...
...RCELONA, Spain, June 15, 2007 /PRNewswire-FirstCal... results regarding the,efficacy and safety of OREN... ongoing investigational study in children with ju...inadequate response to,one or more disease-modifyi...exate (MTX) or tumor necrosis factor (TNF) antagon...
Other Medicine Technology:Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 2Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 3Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 4Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: